James CPA - Longeveron LLC CFO Treasurer
| LGVN Stock | USD 2.05 0.01 0.49% |
Insider
James CPA is CFO Treasurer of Longeveron LLC
| Age | 58 |
| Address | Life Science & Technology Park, Miami, FL, United States, 33136 |
| Phone | 844 470 2550 |
| Web | https://longeveron.com |
Longeveron LLC Management Efficiency
The company has return on total asset (ROA) of (0.6224) % which means that it has lost $0.6224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4216) %, meaning that it created substantial loss on money invested by shareholders. Longeveron LLC's management efficiency ratios could be used to measure how well Longeveron LLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to grow to -2.08. In addition to that, Return On Capital Employed is likely to grow to -2.44. At this time, Longeveron LLC's Total Assets are very stable compared to the past year. As of the 30th of November 2024, Other Current Assets is likely to grow to about 393 K, while Net Tangible Assets are likely to drop about 13.7 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Schneiderman | Pasithea Therapeutics Corp | 46 | |
| Brian Strem | Kiora Pharmaceuticals | 44 | |
| Phillip Samayoa | Generation Bio Co | 37 | |
| Michael Newman | Indaptus Therapeutics | 68 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 55 | |
| Christopher Garcia | Surrozen | N/A | |
| Randall Schatzman | Bolt Biotherapeutics | 69 | |
| Howard MD | ABVC Biopharma | 67 | |
| MS JD | Surrozen | 62 | |
| Nik Chetwyn | Erasca Inc | N/A | |
| James Rolke | Revelation Biosciences | 55 | |
| Antony CPA | Forte Biosciences | 57 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| Stephanie Yao | Kronos Bio | N/A | |
| Gerald Goodman | Nutriband | 76 | |
| Ramtin MD | RenovoRx | 58 | |
| Kristina Zambouras | C4 Therapeutics | N/A | |
| Elizabeth Nguyen | Surrozen | N/A | |
| Jennifer Lachey | Keros Therapeutics | 51 | |
| Andrew Hirsch | C4 Therapeutics | 53 | |
| Noreen MD | Kezar Life Sciences | 59 | |
Management Performance
| Return On Equity | -1.42 | ||||
| Return On Asset | -0.62 |
Longeveron LLC Leadership Team
Elected by the shareholders, the Longeveron LLC's board of directors comprises two types of representatives: Longeveron LLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Longeveron. The board's role is to monitor Longeveron LLC's management team and ensure that shareholders' interests are well served. Longeveron LLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Longeveron LLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Rash, VP Discovery | ||
| Mohamed Hashad, CEO Director | ||
| KwanHong MD, Chief CEO | ||
| James CPA, CFO Treasurer | ||
| Tavara CPA, VP Controller | ||
| Paul JD, General Director | ||
| Nataliya MD, Chief Officer | ||
| Lisa McClainMoss, Vice Manufacturing | ||
| MD FACC, Chief CoFounder | ||
| Mohamed MBA, CEO Director | ||
| Dan Gincel, Senior Affairs | ||
| Elly Ryu, VP Controller | ||
| Michael Mannarino, VP Controller | ||
| Lisa MBA, Executive Officer | ||
| Lisa Locklear, Executive Officer |
Longeveron Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Longeveron LLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.42 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (7.48) % | ||||
| Current Valuation | 9.24 M | ||||
| Shares Outstanding | 13.35 M | ||||
| Shares Owned By Insiders | 10.70 % | ||||
| Shares Owned By Institutions | 3.34 % | ||||
| Number Of Shares Shorted | 1.13 M | ||||
| Price To Book | 1.19 X | ||||
| Price To Sales | 24.75 X |
Pair Trading with Longeveron LLC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Longeveron LLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longeveron LLC will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Longeveron LLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Longeveron LLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Longeveron LLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Longeveron LLC to buy it.
The correlation of Longeveron LLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Longeveron LLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Longeveron LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Longeveron LLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Longeveron LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Longeveron Stock, please use our How to Invest in Longeveron LLC guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longeveron LLC. If investors know Longeveron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longeveron LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.62) | Revenue Per Share 0.364 | Quarterly Revenue Growth 1.157 | Return On Assets (0.62) | Return On Equity (1.42) |
The market value of Longeveron LLC is measured differently than its book value, which is the value of Longeveron that is recorded on the company's balance sheet. Investors also form their own opinion of Longeveron LLC's value that differs from its market value or its book value, called intrinsic value, which is Longeveron LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longeveron LLC's market value can be influenced by many factors that don't directly affect Longeveron LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longeveron LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longeveron LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longeveron LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.